- Home
- / Lionco Pharmaceutical Group
Lionco Pharmaceutical Group
Stock Price
¥4.9
2024-10-29
Market Capitalization
¥3.7 B
2024-10-29
Revenue
¥364.7 M
FY, 2024
Lionco Pharmaceutical Group Summary
Company Summary
- Overview
- Lionco Pharmaceutical Group (灵康药业集团股份有限公司) is a company that produces and develops pharmaceuticals. It offers nutrition, antimicrobial, digestive, detoxification, and other products.
- Type
- Public
- Status
- Active
- Founded
- 2003
- Website
- http://www.lingkang.com.cn
- Cybersecurity rating
- Sectors
Table of Contents
Lionco Pharmaceutical Group Financials
Summary Financials
- Revenue (Q1, 2026)
- ¥85.6M
- Gross profit (Q1, 2026)
- ¥24.0M
- Net income (Q1, 2026)
- ¥3.0M
- Cash (Q1, 2026)
- ¥142.0M
- EBIT (Q1, 2026)
- ¥8.7M
- Enterprise value
- $3.9B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026